Fresenius Gobbles Up APP Pharma Foreign companies are looking to the U.S.to strike pharmaceutical gold.
On Monday German medical group Fresenius SE announced it agreed to buy U.S.
injectable drug maker APP Pharmaceuticals (nasdaq: APPX - news - people ) for $3.7...
Fresenius Falls For APP Pharma The world's richest drug market is becoming a pharmaceutical playground as foreign companies take advantage of the weakening dollar to gobble up U.S.pharma companies.
On Monday German medical group Fresenius SE announced it agreed to...
APP Pharmaceuticals sale to make L.A. billionaire Patrick Soon-Shiong even richer Billionaire drug developer Patrick Soon-Shiong of West Los Angeles should be moving up the list of the nation's richest people with a deal Sunday to sell a pharmaceutical company for $3.7 billion in cash.Soon-Shiong and other directors...
Elan announces encouraging results from Alzheimer drug trials Pharmaceutical firm Elan announced that initial findings from its phase two study of its bapineuzumab drug, used to treat Alzheimer's disease, are encouraging.The 18-month trial, in conjunction with Wyeth Pharmaceuticals, shows that...
Abraxis Appeals $55 Million Patent Infringement Judgment Check out our free and informative ezines and sign up now Sign Up A federal jury awarded neuroscience-based biotech Elan Pharma International $55.2 million and a 6 percent royalty rate in its patent infringement suit against Abraxis...
Abraxis BioScience, Inc. - ABRAXANE in Combination with Trastuzumab and Carboplatin Evaluated as First-Line Tr Abraxis BioScience, Inc.(NASDAQ:ABII), a fully integrated, global company, announced the presentation of results from an ongoing single-arm, open-label, Phase II evaluating solvent-free ABRAXANE(R) for Injectable Suspension (paclitaxel...
Abraxis to appeal patent infringement ruling Abraxis BioScience has announced its intention to appeal a patent infringement decision that went against it, relating to cancer drug Abraxane. Drug maker Elan won US$55.2million when a federal jury decided Abraxis BioScience had...
Abraxis to appeal jury ruling on Elan patent infringement lawsuit In the suit, Elan claimed that Abraxis infringed upon two of its patents 5,834,025 and 5,399,363, asserting Abraxane uses technology protected by Elan-owned patents.Elan later withdrew its claim that Abraxis infringed its 025 patent...
Elan wins $55M judgment in patent scrap Ireland's Elan won a $55.2 million judgment against Abraxis BioScience on Friday, prevailing in its case that Abraxis' breast cancer drug Abraxane uses a technology protected by an Elan patent.Abraxane was approved by the FDA...
Abraxis to Appeal Jury Ruling on Elan Patent Infringement Claim - Abraxis BioScience, Inc.(NASDAQ:ABII), a fully integrated, global biotechnology company, today announced that it intends to appeal the jury ruling in the U.S.
District Court for the District of Delaware that Abraxis has infringed upon...
Abraxis to appeal jury ruling on Elan patent infringement lawsuit Abraxis BioScience has announced that it intends to appeal the jury ruling in the US District Court of Delaware that Abraxis has infringed upon a patent owned by Elan.In the suit, Elan claimed that Abraxis infringed upon two of its patents 5...
Abraxis to Appeal Jury Ruling on Elan Patent Infringement Claim Abraxis BioScience, Inc.(NASDAQ:ABII), a fully integrated, global biotechnology company, today announced that it intends to appeal the jury ruling in the U.S.
District Court for the District of Delaware that Abraxis has infringed upon a...
Elan wins $55.2m in damages after rival infringes medical patents From ireland.com PHARMACEUTICAL FIRM Elan has won $55.2 million (35.99 million) in damages following a case it brought against its rival, Abraxis BioScience, a US biotechnology company.Following an eight-day trial, a federal court in...
Abraxis to appeal patent ruling in Abraxane dispute with Elan SAN FRANCISCO (Thomson Financial) - Abraxis BioScience Inc.late Friday said it is appealing a jury ruling that said the company infringed upon a patent held by Elan Corp.
According to Abraxis, in the lawsuit Elan claimed the company...
Abraxis to Appeal Jury Ruling on Elan Patent Infringement Claim Abraxis BioScience, Inc.(NASDAQ:ABII), a fully integrated, global biotechnology company, today announced that it intends to appeal the jury ruling in the U.S.
District Court for the District of Delaware that Abraxis has infringed upon a...
Abraxis to Appeal Jury Ruling on Elan Patent Infringement Claim Abraxis BioScience, Inc.(ABII), a fully integrated, global biotechnology company, today announced that it intends to appeal the jury ruling in the U.S.
District Court for the District of Delaware that Abraxis has infringed upon a patent...
Abraxis to Appeal Jury Ruling on Elan Patent Infringement Claim Abraxis BioScience, (News) Inc.(NASDAQ:ABII), a fully integrated, global biotechnology company, today announced that it intends to appeal the jury ruling in the U.S.
District Court for the District of Delaware that Abraxis has infringed...
Abraxis to Appeal Jury Ruling on Elan Patent Infringement Claim LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc.(NASDAQ:ABII), a fully integrated, global biotechnology company, today announced that it intends to appeal the jury ruling in the U.S.
District Court for the District of Delaware...
Abraxis to Appeal Jury Ruling on Elan Patent Infringement Claim LOS ANGELES - (Business Wire) Abraxis BioScience, Inc.(NASDAQ:ABII), a fully integrated, global biotechnology company, today announced that it intends to appeal the jury ruling in the U.S.
District Court for the District of Delaware...
Abraxis to Appeal Jury Ruling on Elan Patent Infringement Claim LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc.(NASDAQ:ABII - News), a fully integrated, global biotechnology company, today announced that it intends to appeal the jury ruling in the U.S.
District Court for the District of...
Abraxis to Appeal Jury Ruling on Elan Patent Infringement Claim LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc.(NASDAQ:ABII - News), a fully integrated, global biotechnology company, today announced that it intends to appeal the jury ruling in the U.S.
District Court for the District of...
Abraxis to appeal patent ruling in Abraxane dispute with Elan SAN FRANCISCO (Thomson Financial) - Abraxis BioScience Inc.late Friday said it is appealing a jury ruling that said the company infringed upon a patent held by Elan Corp.
According to Abraxis, in the lawsuit Elan (nyse: ELN - news -...
Abraxis to appeal patent ruling in Abraxane dispute with Elan SAN FRANCISCO (Thomson Financial) - Abraxis BioScience Inc.late Friday said it is appealing a jury ruling that said the company infringed upon a patent held by Elan Corp.
According to Abraxis, in the lawsuit Elan claimed the company...
Abraxis to appeal patent ruling in Abraxane dispute with Elan Home Company Profile Company Philosophy Product Philosophy Professional Products Focus Products Partners Delivery Press releases AFX Newsletters Career Opportunities Contact Member Service SAN FRANCISCO (Thomson Financial) - Abraxis...
Abraxis to appeal patent ruling in Abraxane dispute with Elan SAN FRANCISCO (Thomson Financial) - Abraxis BioScience Inc.late Friday said it is appealing a jury ruling that said the company infringed upon a patent held by Elan Corp.
According to Abraxis, in the lawsuit Elan claimed the company...
